UNSPSC 51182221: Dinoprost tromethamine

This classification denotes a prostaglandin analogue with the molecular formula C20H34O5.C4H11NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CT6BBQ5A68, chemically known as (e,z)-(1r,2r,3r,5s)-7-(3,5-dihydroxy-2-((3s)-(3-hydroxy-1-octenyl))cyclopentyl)-5-heptenoic acid compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1), but more generally known as dinoprost tromethamine, which bears US NIH Compound Identifier 5282415.

UNSPSC 51182221 Dinoprost tromethamine is a Commodity code representing pharmaceutical products procured by state and local health agencies through cooperative purchasing vehicles. State and local governments acquire dinoprost tromethamine and similar injectable pharmaceuticals for use in public health facilities, animal-control programs, and veterinary services. The code shows activity primarily through multistate cooperative purchasing alliances rather than individual jurisdiction RFPs; participating entities leverage negotiated pricing and established wholesaler networks to standardize procurement across member states and agencies.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP on January 20, 2026 (S1070000015802) to establish multiple contracts for generic pharmaceuticals and OTC products with a response deadline of March 26, 2026. The solicitation requires vendors to meet cGMP certification and Drug Supply Chain Security Act compliance, maintain relationships with at least two of three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, Morris & Dickson Co., LLC), and provide products through multiple pricing structures including flat price, net price formats, and WAC-minus options. Awarded contracts become effective July 1, 2026 for a two-year initial term with optional extensions; the evaluation weighs price competitiveness at 75 percent, with the remainder distributed across fixed pricing, administrative fee compliance, EDI capability, and pricing flexibility. Participating jurisdictions span Minnesota and Oregon, with the cooperative structure enabling smaller and mid-sized municipal health departments, county facilities, and state agencies to access volume-based pricing without managing individual solicitations.